KCNH2 and epilepsy: Post-mortem genetic analysis indicates a higher prevalence of LOF (3-fold) and rare (11-fold) KCNH2 variants in Sudden Unexpected Death in Epilepsy (SUDEP) cases vs. living epilepsy controls [12].